Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00004913 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004913 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study of Docetaxel Plus 5-FU, Cisplatin and Leucovorin in Patients With Advanced Solid Tumors |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, docetaxel, fluorouracil, leucovorin calcium |
| Start date | Jan 1, 2000 |
| Primary completion | May 1, 2002 |
| Completion | May 1, 2002 |
| First posted | Mar 16, 2004 |
| Last update posted | Jun 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: